42Stockpicking

ARDX

Ardelyx Inc
NASDAQ·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
EV/EBITDAi
P/Bi
11,3
86th %ile · 404p
P/Si
211,4
92nd %ile · 356p
EV/Salesi
233,2
94th %ile · 356p
Div yieldi

Kursudvikling

Kun 87 handelsdage i databasen. Viser al tilgængelig historik.

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 10.6.2026none
Prishistorik
0,3 år
Pris-dage
63
Årsregnskaber
15
Peers
0/0
Valuation
3/6
Fundamentals
8/8
Datovindue
2026-02-09 til 2026-05-08

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Mangler ca. 9,8 års prishistorik før ideal/full.
  • Backfill mindst 1 års daglige priser før seriøs teknisk vurdering.
  • Kør compute-multiples for manglende valuation metrics.

Seneste assessment

ARDX vurderet 2026-06-10

Score
30.8%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

60%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

19%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

58%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

54%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

46%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

30%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

36%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: P/E relative valuation needs both own multiple and peer median.

Insider activity

Net 90d (aktier)
-196.022
Net 90d (værdi)
-1.181.435 USD
Købere 90d
0
Cluster
DatoPersonRolleTypeAntalVærdiKilde
18.6.2026Williams Laura AChief Patient Officer▼ SALG-81.898-490.487 USDsec
18.6.2026Williams Laura AChief Patient Officer◆ OPT.31.00030.690 USDsec
16.6.2026Cadoret-Manier Onaiza· ANDET26.455sec
16.6.2026Parsey Merdad· ANDET26.455sec
16.6.2026Bazemore Robert B· ANDET26.455sec
16.6.2026Rodgers Richard J· ANDET26.455sec
16.6.2026MOTT DAVID M· ANDET20.282sec
16.6.2026Bertrand William C JR· ANDET12.345sec
16.6.2026Bhanji Muna· ANDET26.455sec
15.6.2026RAAB MICHAELPresident & CEO◆ OPT.20.83320.625 USDsec
15.6.2026RAAB MICHAELPresident & CEO▼ SALG-41.666-236.346 USDsec
21.5.2026Bishop John ESee Remarks▼ SALG-2.306-14.453 USDsec
21.5.2026Hohenleitner SusanChief Financial Officer▼ SALG-1.455-9.119 USDsec
21.5.2026Brady James ParkerChief Human Resources Officer▼ SALG-1.846-11.570 USDsec
21.5.2026Reilly Joseph JamesSee Remarks▼ SALG-2.683-16.816 USDsec
21.5.2026Foster Eric DuaneChief Commercial Officer▼ SALG-3.166-19.843 USDsec
21.5.2026Kelliher MikeChief Business Officer▼ SALG-2.900-18.176 USDsec
21.5.2026Williams Laura AChief Patient Officer▼ SALG-1.503-9.420 USDsec
21.5.2026RAAB MICHAELPresident & CEO▼ SALG-14.933-93.593 USDsec
15.5.2026RAAB MICHAELPresident & CEO◆ OPT.20.83320.625 USDsec

Earnings

QuarterDateEPS actualEPS estEPS surpriseRevenue surprise
2026Q130.4.2026-0,15-0,14-5.0%-5.0%Miss
2025Q430.1.20260,000,01-100.0%-100.0%Miss
2025Q330.10.20250,00-0,07+100.0%+100.0%Beat
2025Q230.7.2025-0,08-0,14+41.5%+41.5%Beat